Terumo Corp.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Ebitda" stands at 261.52 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Terumo Corp.'s second quarter result of 67.79 Billion JPY for the item "Ebitda" represents a decrease of -13.03 percent compared to it's first quarter result.
Also, Terumo Corp.'s second quarter result of 67.79 Billion JPY for the item "Ebitda" represents an increase of 5.66 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Terumo Corp.'s second quarter result of 261.52 Billion JPY for the item "Ebitda" represents an increase of 1.41 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 5.84 percent compared to the value the year prior.
The 1 year change in percent is 5.84.
The 3 year change in percent is 51.61.
The 5 year change in percent is 77.09.
The 10 year change in percent is 192.72.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Ebitda | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Ebitda | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Ebitda | 172,241,486,586.05 |
![]() | Danaher Corporation - Ebitda | 162,006,663,168.00 |
![]() | Boston Scientific Corp - Ebitda | 144,567,730,176.00 |